{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:58:40Z","timestamp":1786993120606,"version":"build-2736575974"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jocn.2025.111517","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T06:46:17Z","timestamp":1753339577000},"page":"111517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Biomarkers in normal pressure hydrocephalus: A mini review"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1148-7085","authenticated-orcid":false,"given":"Anderson Silva","family":"Corin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6242-7279","authenticated-orcid":false,"given":"Gabriel","family":"Semione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5612-556X","authenticated-orcid":false,"given":"Leonardo B.O.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4789-6019","authenticated-orcid":false,"given":"Anderson M.P.","family":"Da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5326-8297","authenticated-orcid":false,"given":"Romualdo","family":"de Freitas Ruiz Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6803-9060","authenticated-orcid":false,"given":"Isabela Zampirolli","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5918-3873","authenticated-orcid":false,"given":"Jo\u00e3o Victor","family":"de Oliveira Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1244-4447","authenticated-orcid":false,"given":"Maria Fernanda P.","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Henrique","family":"de Oliveira Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6546-2634","authenticated-orcid":false,"given":"Raphael","family":"Bertani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2025.111517_b0005","doi-asserted-by":"crossref","unstructured":"Kamalian A, Shirzadeh Barough S, Ho SG, et al. Molecular signatures of normal pressure hydrocephalus: a large-scale proteomic analysis of cerebrospinal fluid. Fluids Barriers CNS. 2024;21(1):64. Published 2024 Aug 8. doi:10.1186\/s12987-024-00561-5.","DOI":"10.1186\/s12987-024-00561-5"},{"key":"10.1016\/j.jocn.2025.111517_b0010","doi-asserted-by":"crossref","unstructured":"Gr\u00f8nning R, Jeppsson A, Hellstr\u00f6m P, et al. Association between ventricular CSF biomarkers and outcome after shunt surgery in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. 2023;20(1):77. Published 2023 Oct 25. doi:10.1186\/s12987-023-00475-8.","DOI":"10.1186\/s12987-023-00475-8"},{"key":"10.1016\/j.jocn.2025.111517_b0015","doi-asserted-by":"crossref","unstructured":"Oernbo EK, Steffensen AB, Gredal H, et al. Cerebrospinal fluid osmolality cannot predict development or surgical outcome of idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. 2022;19(1):52. Published 2022 Jun 27. doi:10.1186\/s12987-022-00349-5.","DOI":"10.1186\/s12987-022-00349-5"},{"issue":"15","key":"10.1016\/j.jocn.2025.111517_b0020","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/WNL.0b013e31828c2fda","article-title":"Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers","volume":"80","author":"Jeppsson","year":"2013","journal-title":"Neurology."},{"issue":"3","key":"10.1016\/j.jocn.2025.111517_b0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00702-003-0075-x","article-title":"Immunoreactivities of amyloid \u03b2 peptide(1\u201342) and total \u03c4 protein in lumbar cerebrospinal fluid of patients with normal pressure hydrocephalus","volume":"111","author":"Lins","year":"2004","journal-title":"J Neural Transm."},{"issue":"5","key":"10.1016\/j.jocn.2025.111517_b0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1600-0404.2007.00890.x","article-title":"CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus","volume":"116","author":"Agren-Wilsson","year":"2007","journal-title":"Acta Neurol Scand."},{"issue":"1\u20132","key":"10.1016\/j.jocn.2025.111517_b0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jns.2015.07.001","article-title":"Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus","volume":"357","author":"Nakajima","year":"2015","journal-title":"J Neurol Sci."},{"issue":"3","key":"10.1016\/j.jocn.2025.111517_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091974","article-title":"Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus","volume":"9","author":"Pyykk\u00f6","year":"2014","journal-title":"PLoS One."},{"issue":"1","key":"10.1016\/j.jocn.2025.111517_b0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JAD-142622","article-title":"Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease","volume":"45","author":"Jingami","year":"2015","journal-title":"J Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.jocn.2025.111517_b0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12987-022-00309-z","article-title":"Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients","volume":"19","author":"Lukkarinen","year":"2022","journal-title":"Fluids Barriers CNS."},{"issue":"2","key":"10.1016\/j.jocn.2025.111517_b0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/CPJ.0000000000001156","article-title":"CSF biomarkers predict gait outcomes in idiopathic normal pressure hydrocephalus","volume":"12","author":"Darrow","year":"2022","journal-title":"Neurol Clin Pract."},{"key":"10.1016\/j.jocn.2025.111517_b0060","doi-asserted-by":"crossref","unstructured":"Djukic M, Spreer A, Lange P, Bunkowski S, Wiltfang J, Nau R. Small cisterno-lumbar gradient of phosphorylated Tau protein in geriatric patients with suspected normal pressure hydrocephalus. Fluids Barriers CNS. 2016;13(1):15. Published 2016 Aug 31. doi:10.1186\/s12987-016-0039-9.","DOI":"10.1186\/s12987-016-0039-9"},{"key":"10.1016\/j.jocn.2025.111517_b0065","doi-asserted-by":"crossref","unstructured":"Rostgaard N, Olsen MH, Ottenheijm M, et al. Differential proteomic profile of lumbar and ventricular cerebrospinal fluid. Fluids Barriers CNS. 2023;20(1):6. Published 2023 Jan 21. doi:10.1186\/s12987-022-00405-0.","DOI":"10.1186\/s12987-022-00405-0"},{"issue":"1","key":"10.1016\/j.jocn.2025.111517_b0070","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3233\/JAD-220652","article-title":"Concordance of Alzheimer's Disease-Related Biomarkers Between Intraventricular and Lumbar Cerebrospinal Fluid in Idiopathic Normal Pressure Hydrocephalus","volume":"91","author":"Lukkarinen","year":"2023","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.jocn.2025.111517_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1364325","article-title":"Lipocalin-type prostaglandin D synthase: a glymphopathy marker in idiopathic hydrocephalus","volume":"16","author":"Nishida","year":"2024","journal-title":"Front Aging Neurosci."},{"issue":"2","key":"10.1016\/j.jocn.2025.111517_b0080","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3233\/JAD-230144","article-title":"Cerebrospinal Fluid Diagnostics of Alzheimer's Disease in Patients with Idiopathic Normal Pressure Hydrocephalus","volume":"94","author":"Vanninen","year":"2023","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.jocn.2025.111517_b0085","doi-asserted-by":"crossref","unstructured":"Klemke LL, M\u00fcller-Schmitz K, Kolman A, Seitz RJ. Evolution of neurodegeneration in patients with normal pressure hydrocephalus: a monocentric follow up study. Neurol Res Pract. 2023;5(1):52. Published 2023 Sep 7. doi:10.1186\/s42466-023-00272-6.","DOI":"10.1186\/s42466-023-00272-6"},{"issue":"4","key":"10.1016\/j.jocn.2025.111517_b0090","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3233\/JAD-221180","article-title":"Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus","volume":"93","author":"Yang","year":"2023","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.jocn.2025.111517_b0095","article-title":"Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus","volume":"19(1):15","author":"Braun","year":"2022","journal-title":"Fluids Barriers CNS."},{"key":"10.1016\/j.jocn.2025.111517_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1117675","article-title":"White matter hyperintensity mediating gait disorders in iNPH patients via neurofilament light chain","volume":"15","author":"Yang","year":"2023","journal-title":"Front Aging Neurosci."},{"issue":"11","key":"10.1016\/j.jocn.2025.111517_b0105","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3390\/brainsci13111593","article-title":"Alzheimer\u2019s Disease CSF Biomarkers as Possible Indicators of Tap-Test Response in Idiopathic Normal Pressure Hydrocephalus","volume":"13","author":"Pyrgelis","year":"2023","journal-title":"Brain Sciences."},{"key":"10.1016\/j.jocn.2025.111517_b0110","doi-asserted-by":"crossref","unstructured":"Lid\u00e9n S, Farahmand D, Laurell K. Ventricular volume in relation to lumbar CSF levels of amyloid-\u03b2 1-42, tau and phosphorylated tau in iNPH, is there a dilution effect?. Fluids Barriers CNS. 2022;19(1):59. Published 2022 Jul 17. doi:10.1186\/s12987-022-00353-9.","DOI":"10.1186\/s12987-022-00353-9"},{"key":"10.1016\/j.jocn.2025.111517_b0115","doi-asserted-by":"crossref","unstructured":"Pyrgelis ES, Paraskevas GP, Constantinides VC, Boufidou F, Stefanis L, Kapaki E. In Vivo Prevalence of Beta-Amyloid Pathology and Alzheimer's Disease Co-Pathology in Idiopathic Normal-Pressure Hydrocephalus-Association with Neuropsychological Features. Biomedicines. 2024;12(8):1898. Published 2024 Aug 20. doi:10.3390\/biomedicines12081898.","DOI":"10.3390\/biomedicines12081898"},{"key":"10.1016\/j.jocn.2025.111517_b0120","doi-asserted-by":"crossref","unstructured":"Mazzeo S, Emiliani F, Bagnoli S, et al. Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus. J Pers Med. 2022;12(6):935. Published 2022 Jun 6. doi:10.3390\/jpm12060935.","DOI":"10.3390\/jpm12060935"},{"issue":"3","key":"10.1016\/j.jocn.2025.111517_b0125","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16179","article-title":"Peripheral immunity changes are associated with neurodegeneration and worse clinical outcome in idiopathic normal pressure hydrocephalus","volume":"31","author":"Bissacco","year":"2024","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.jocn.2025.111517_b0130","doi-asserted-by":"crossref","unstructured":"Giannini G, Baiardi S, Dellavalle S, et al. In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome. Fluids Barriers CNS. 2022;19(1):71. Published 2022 Sep 7. doi:10.1186\/s12987-022-00368-2.","DOI":"10.1186\/s12987-022-00368-2"},{"issue":"5","key":"10.1016\/j.jocn.2025.111517_b0135","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/hbm.25308","article-title":"Dynamic functional networks in idiopathic normal pressure hydrocephalus: Alterations and reversibility by CSF tap test","volume":"42","author":"Griffa","year":"2021","journal-title":"Hum Brain Mapp."},{"key":"10.1016\/j.jocn.2025.111517_b0140","doi-asserted-by":"crossref","unstructured":"Torretta E, Arosio B, Barbacini P, et al. Novel Insight in Idiopathic Normal Pressure Hydrocephalus (iNPH) Biomarker Discovery in CSF. Int J Mol Sci. 2021;22(15):8034. Published 2021 Jul 27. doi:10.3390\/ijms22158034.","DOI":"10.3390\/ijms22158034"},{"key":"10.1016\/j.jocn.2025.111517_b0145","article-title":"Elevated CSF LRG and Decreased Alzheimer's Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus","volume":"10(5):1105","author":"Vanninen","year":"2021","journal-title":"J Clin Med."},{"issue":"1","key":"10.1016\/j.jocn.2025.111517_b0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/01616412.2020.1831300","article-title":"P-Tau as prognostic marker in long term follow up for patients with shunted iNPH","volume":"43","author":"Migliorati","year":"2021","journal-title":"Neurol Res."},{"issue":"3","key":"10.1016\/j.jocn.2025.111517_b0155","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3233\/JAD-200036","article-title":"Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease","volume":"75","author":"Manniche","year":"2020","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.jocn.2025.111517_b0160","article-title":"Diagnostic value of plasma chitinase 3-like 1 (CHI3L1) protein levels and cerebrospinal fluid biomarkers (A\u03b242, total tau, phosphorylated tau) in idiopathic normal-pressure hydrocephalus","volume":"425","author":"Ko","year":"2021","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.jocn.2025.111517_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.839307","article-title":"Shared CSF Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus and Subcortical Small Vessel Disease","volume":"13","author":"Jeppsson","year":"2022","journal-title":"Front Neurol."},{"issue":"1","key":"10.1016\/j.jocn.2025.111517_b0170","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JAD-210226","article-title":"Cerebrospinal Fluid Amyloid-\u03b2 Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus","volume":"83","author":"Kawamura","year":"2021","journal-title":"J Alzheimers Dis."},{"issue":"5\u20136","key":"10.1016\/j.jocn.2025.111517_b0175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000514052","article-title":"Cerebrospinal Fluid Alzheimer's Biomarkers and Neurofilament Light Profile of Idiopathic Normal Pressure Hydrocephalus in China: A PUMCH Cohort Study","volume":"20","author":"Mao","year":"2020","journal-title":"Neurodegener Dis."},{"issue":"4","key":"10.1016\/j.jocn.2025.111517_b0180","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3233\/JAD-201361","article-title":"Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus","volume":"80","author":"Lukkarinen","year":"2021","journal-title":"J Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.jocn.2025.111517_b0185","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3233\/JAD-190775","article-title":"Two-Point Dynamic Observation of Alzheimer\u2019s Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus","volume":"72","author":"Jingami","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease."},{"issue":"5","key":"10.1016\/j.jocn.2025.111517_b0190","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/23279095.2020.1818563","article-title":"The applause sign in elderly patients with idiopathic normal pressure hydrocephalus","volume":"29","author":"Kaya","year":"2020","journal-title":"Applied Neuropsychology: Adult"},{"key":"10.1016\/j.jocn.2025.111517_b0195","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/psyg.12435","article-title":"Cerebral blood flow and Alzheimer's disease-related biomarkers in cerebrospinal fluid in idiopathic normal pressure hydrocephalus","volume":"19","author":"Azuma","year":"2019","journal-title":"Psychogeriatrics"},{"issue":"2","key":"10.1016\/j.jocn.2025.111517_b0200","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3233\/JAD-181012","article-title":"Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study","volume":"68","author":"Abu-Rumeileh","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease."},{"issue":"9","key":"10.1016\/j.jocn.2025.111517_b0205","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1017\/S1355617720000387","article-title":"Frontal Behavior Syndromes in Idiopathic Normal Pressure Hydrocephalus as a Function of Alzheimer's Disease Biomarker Status","volume":"26","author":"Niermeyer","year":"2020","journal-title":"J Int Neuropsychol Soc."},{"issue":"3","key":"10.1016\/j.jocn.2025.111517_b0210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3988\/jcn.2019.15.3.353","article-title":"Cerebrospinal Fluid Levels of \u03b2-Amyloid 40 and \u03b2-Amyloid 42 are Proportionately Decreased in Amyloid Positron-Emission Tomography Negative Idiopathic Normal-Pressure Hydrocephalus Patients","volume":"15","author":"Kim","year":"2019","journal-title":"J Clin Neurol."},{"issue":"1","key":"10.1016\/j.jocn.2025.111517_b0215","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JAD-170186","article-title":"Cerebrospinal Fluid Amyloid-\u03b2 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease","volume":"60","author":"Santangelo","year":"2017","journal-title":"J Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.jocn.2025.111517_b0220","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3233\/JAD-142862","article-title":"Amyloid-\u03b2 and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus","volume":"46","author":"Herukka","year":"2015","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.jocn.2025.111517_b0225","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jns.2016.08.040","article-title":"Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus","volume":"369","author":"Kazui","year":"2016","journal-title":"J Neurol Sci."},{"issue":"5","key":"10.1016\/j.jocn.2025.111517_b0230","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/NEN.0000000000000191","article-title":"Correlations between mini-mental state examination score, cerebrospinal fluid biomarkers, and pathology observed in brain biopsies of patients with normal-pressure hydrocephalus","volume":"74","author":"Elobeid","year":"2015","journal-title":"J Neuropathol Exp Neurol."},{"issue":"3","key":"10.1016\/j.jocn.2025.111517_b0235","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3233\/JAD-180059","article-title":"Change of Amyloid-\u03b2 1-42 Toxic Conformer Ratio After Cerebrospinal Fluid Diversion Predicts Long-Term Cognitive Outcome in Patients with Idiopathic Normal Pressure Hydrocephalus","volume":"63","author":"Akiba","year":"2018","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.jocn.2025.111517_b0240","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fneur.2015.00086","article-title":"A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus","volume":"6","author":"Schirinzi","year":"2015","journal-title":"Front Neurol."},{"issue":"1","key":"10.1016\/j.jocn.2025.111517_b0245","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3171\/2017.7.JNS171005","article-title":"Brain tissue A\u03b242 levels are linked to shunt response in idiopathic normal pressure hydrocephalus","volume":"130","author":"Abu Hamdeh","year":"2019","journal-title":"J Neurosurg."},{"issue":"1","key":"10.1016\/j.jocn.2025.111517_b0250","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-8118-11-9","article-title":"Association of lipocalin-type prostaglandin D synthase with disproportionately enlarged subarachnoid-space in idiopathic normal pressure hydrocephalus","volume":"11","author":"Nishida","year":"2014","journal-title":"Fluids Barriers CNS."},{"issue":"4","key":"10.1016\/j.jocn.2025.111517_b0255","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3233\/JAD-132708","article-title":"Ventricular and lumbar cerebrospinal fluid concentrations of Alzheimer's disease biomarkers in patients with normal pressure hydrocephalus and posttraumatic hydrocephalus","volume":"41","author":"Brandner","year":"2014","journal-title":"J Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.jocn.2025.111517_b0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119973","article-title":"Impact of cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus on the amyloid cascade","volume":"10","author":"Moriya","year":"2015","journal-title":"PLoS One."},{"issue":"12","key":"10.1016\/j.jocn.2025.111517_b0265","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s00701-016-2980-4","article-title":"Multimodal analysis to predict shunt surgery outcome of 284 patients with suspected idiopathic normal pressure hydrocephalus","volume":"158","author":"Luikku","year":"2016","journal-title":"Acta Neurochir (Wien)."},{"issue":"8","key":"10.1016\/j.jocn.2025.111517_b0270","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.jocn.2013.11.039","article-title":"Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test","volume":"21","author":"Kang","year":"2014","journal-title":"J Clin Neurosci."},{"key":"10.1016\/j.jocn.2025.111517_b0275","doi-asserted-by":"crossref","unstructured":"Jeppsson A, H\u00f6ltta M, Zetterberg H, Blennow K, Wikkels\u00f8 C, Tullberg M. Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. 2016;13(1):13. Published 2016 Jul 29. doi:10.1186\/s12987-016-0037-y.","DOI":"10.1186\/s12987-016-0037-y"},{"issue":"12","key":"10.1016\/j.jocn.2025.111517_b0280","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00701-017-3314-x","article-title":"The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus","volume":"159","author":"Craven","year":"2017","journal-title":"Acta Neurochir (Wien)."},{"issue":"2","key":"10.1016\/j.jocn.2025.111517_b0285","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1468-1331.2006.01593.x","article-title":"Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease","volume":"14","author":"Kapaki","year":"2007","journal-title":"Eur J Neurol."},{"issue":"2","key":"10.1016\/j.jocn.2025.111517_b0290","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1468-1331.2012.03781.x","article-title":"Soluble amyloid precursor protein \u03b1 in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus","volume":"20","author":"Miyajima","year":"2013","journal-title":"Eur J Neurol."},{"issue":"10","key":"10.1016\/j.jocn.2025.111517_b0295","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1136\/jnnp.2008.171686","article-title":"The longitudinal profile of CSF markers during external lumbar drainage","volume":"80","author":"Tarnaris","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"4","key":"10.1016\/j.jocn.2025.111517_b0300","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jpsychires.2010.07.011","article-title":"Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: change in CSF levels of amyloid precursor protein (APP), amyloid-beta (A\u03b2) peptide and phospho-tau","volume":"45","author":"Ray","year":"2011","journal-title":"J Psychiatr Res."},{"key":"10.1016\/j.jocn.2025.111517_b0305","article-title":"Phosphorylated tau\/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus","volume":"9(1):7","author":"Patel","year":"2012","journal-title":"Fluids Barriers CNS."},{"key":"10.1016\/j.jocn.2025.111517_b0310","doi-asserted-by":"crossref","unstructured":"Said HM, Kaya D, Yavuz I, Dost FS, Altun ZS, Isik AT. A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias. Clin Interv Aging. 2022;17:467-477. Published 2022 Apr 11. doi:10.2147\/CIA.S360736.","DOI":"10.2147\/CIA.S360736"},{"key":"10.1016\/j.jocn.2025.111517_b0315","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.665878","article-title":"Predictive Value of Cerebrospinal Fluid Biomarkers for Tap Test Responsiveness in Patients With Suspected Idiopathic Normal Pressure Hydrocephalus","volume":"13","author":"Hua","year":"2021","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.jocn.2025.111517_b0320","article-title":"Cerebrospinal fluid biomarkers in normal pressure hydrocephalus","volume":"94(15_supplement):2412","author":"Taghdiri","year":"2020","journal-title":"Neurology."},{"issue":"10","key":"10.1016\/j.jocn.2025.111517_b0325","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/jnnp-2019-320826","article-title":"CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics","volume":"90","author":"Jeppsson","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"4","key":"10.1016\/j.jocn.2025.111517_b0330","article-title":"Differences in Cerebrospinal Fluid Biomarkers between Clinically Diagnosed Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease","volume":"4","author":"Tsai","year":"2014","journal-title":"J Alzheimers Dis Parkinsonism."},{"issue":"1","key":"10.1016\/j.jocn.2025.111517_b0335","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/197140091302600107","article-title":"Distribution of amyloid burden differs between idiopathic normal pressure hydrocephalus and Alzheimer's disease","volume":"26","author":"Kondo","year":"2013","journal-title":"Neuroradiol J."},{"issue":"1","key":"10.1016\/j.jocn.2025.111517_b0340","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-180557","article-title":"Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus","volume":"66","author":"Nakajima","year":"2018","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.jocn.2025.111517_b0345","article-title":"Comparison of cerebrospinal fluid biomarkers between idiopathic normal pressure hydrocephalus and subarachnoid hemorrhage-induced chronic hydrocephalus: a pilot study","volume":"18(12):PR19-PR25","author":"Lee","year":"2012","journal-title":"Med Sci Monit."},{"issue":"5","key":"10.1016\/j.jocn.2025.111517_b0350","first-page":"e1265","article-title":"Cerebrospinal Fluid Total Tau is Increased in Normal Pressure Hydrocephalus Patients who Undergo Successful Lumbar Drain Trials","volume":"9","author":"Baird","year":"2017","journal-title":"Cureus."},{"issue":"1","key":"10.1016\/j.jocn.2025.111517_b0355","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jnnp.69.1.74","article-title":"CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy","volume":"69","author":"Tullberg","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.jocn.2025.111517_b0360","doi-asserted-by":"crossref","unstructured":"Lolansen SD, Rostgaard N, Andreassen SN, et al. Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus. Fluids Barriers CNS. 2021;18(1):54. Published 2021 Dec 4. doi:10.1186\/s12987-021-00289-6.","DOI":"10.1186\/s12987-021-00289-6"},{"key":"10.1016\/j.jocn.2025.111517_b0365","doi-asserted-by":"crossref","unstructured":"Jeppsson A, Sandelius \u00c5, Zettergren A, et al. Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. 2023;20(1):54. Published 2023 Jul 6. doi:10.1186\/s12987-023-00455-y.","DOI":"10.1186\/s12987-023-00455-y"},{"issue":"6","key":"10.1016\/j.jocn.2025.111517_b0370","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00701-011-0963-z","article-title":"Leucine-rich \u03b1-2-glycoprotein is a marker for idiopathic normal pressure hydrocephalus","volume":"153","author":"Nakajima","year":"2011","journal-title":"Acta Neurochir (Wien)."},{"issue":"2","key":"10.1016\/j.jocn.2025.111517_b0375","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2006.11.039","article-title":"Expression of TGF-betas and TGF-beta type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus","volume":"413","author":"Li","year":"2007","journal-title":"Neurosci Lett."},{"issue":"8","key":"10.1016\/j.jocn.2025.111517_b0380","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00701-006-0787-4","article-title":"Analysis of potential diagnostic biomarkers in cerebrospinal fluid of idiopathic normal pressure hydrocephalus by proteomics","volume":"148","author":"Li","year":"2006","journal-title":"Acta Neurochir (Wien)."},{"issue":"1\u20132","key":"10.1016\/j.jocn.2025.111517_b0385","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jim.2004.01.015","article-title":"An ELISA for glial fibrillary acidic protein","volume":"287","author":"Petzold","year":"2004","journal-title":"J Immunol Methods."},{"issue":"3","key":"10.1016\/j.jocn.2025.111517_b0390","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10072-009-0181-0","article-title":"CSF proteomic analysis in patients with normal pressure hydrocephalus selected for the shunt: CSF biomarkers of response to surgical treatment","volume":"31","author":"Scollato","year":"2010","journal-title":"Neurol Sci."},{"issue":"4","key":"10.1016\/j.jocn.2025.111517_b0395","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5114\/fn.2017.72389","article-title":"Levels of selected pro- and anti-inflammatory cytokines in cerebrospinal fluid in patients with hydrocephalus","volume":"55","author":"Czubowicz","year":"2017","journal-title":"Folia Neuropathol."},{"issue":"10","key":"10.1016\/j.jocn.2025.111517_b0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258165","article-title":"Evaluation of aquaporins in the cerebrospinal fluid in patients with idiopathic normal pressure hydrocephalus","volume":"16","author":"Hiraldo-Gonz\u00e1lez","year":"2021","journal-title":"PLoS One."},{"issue":"3","key":"10.1016\/j.jocn.2025.111517_b0405","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3233\/JAD-190119","article-title":"Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?","volume":"69","author":"Arighi","year":"2019","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.jocn.2025.111517_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577407","article-title":"AQP4 autoantibodies in patients with idiopathic normal pressure hydrocephalus","volume":"349","author":"Gastaldi","year":"2020","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.jocn.2025.111517_b0415","article-title":"Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus","volume":"18(1):23","author":"Minta","year":"2021","journal-title":"Fluids Barriers CNS."},{"key":"10.1016\/j.jocn.2025.111517_b0420","doi-asserted-by":"crossref","unstructured":"Torretta E, Arosio B, Barbacini P, et al. Particular CSF sphingolipid patterns identify iNPH and AD patients [published correction appears in Sci Rep. 2020 Jun 11;10(1):9724. doi: 10.1038\/s41598-020-66184-6]. Sci Rep. 2018;8(1):13639. Published 2018 Sep 11. doi:10.1038\/s41598-018-31756-0.","DOI":"10.1038\/s41598-018-31756-0"},{"issue":"5","key":"10.1016\/j.jocn.2025.111517_b0425","first-page":"e561","article-title":"d-serine levels in Alzheimer's disease: implications for novel biomarker development. Transl","volume":"5","author":"Madeira","year":"2015","journal-title":"Psychiatry."},{"key":"10.1016\/j.jocn.2025.111517_b0430","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40364-018-0119-x","article-title":"Comparative analysis of cerebrospinal fluid metabolites in Alzheimer's disease and idiopathic normal pressure hydrocephalus in a Japanese cohort","volume":"6","author":"Nagata","year":"2018","journal-title":"Biomark Res."},{"issue":"1","key":"10.1016\/j.jocn.2025.111517_b0435","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5603\/pjnns.98212","article-title":"Neuronal pentraxin 2 correlates with neurodegeneration but not cognition in idiopathic normal pressure hydrocephalus (iNPH)","volume":"58","author":"Patel","year":"2024","journal-title":"Neurol Neurochir Pol."},{"issue":"2","key":"10.1016\/j.jocn.2025.111517_b0440","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/ene.14575","article-title":"Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus","volume":"28","author":"Nakajima","year":"2021","journal-title":"Eur J Neurol."},{"issue":"3","key":"10.1016\/j.jocn.2025.111517_b0445","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jb\/mvy043","article-title":"Rapid increase of 'brain-type' transferrin in cerebrospinal fluid after shunt surgery for idiopathic normal pressure hydrocephalus: a prognosis marker for cognitive recovery","volume":"164","author":"Murakami","year":"2018","journal-title":"J Biochem."},{"issue":"1","key":"10.1016\/j.jocn.2025.111517_b0450","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3233\/JAD-160848","article-title":"Decreased Expression of hsa-miR-4274 in Cerebrospinal Fluid of Normal Pressure Hydrocephalus Mimics with Parkinsonian Syndromes","volume":"56","author":"Jurjevi\u0107","year":"2017","journal-title":"J Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.jocn.2025.111517_b0455","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.neurobiolaging.2011.02.023","article-title":"A unique N-glycan on human transferrin in CSF: a possible biomarker for iNPH","volume":"33","author":"Futakawa","year":"2012","journal-title":"Neurobiol Aging."},{"issue":"7","key":"10.1016\/j.jocn.2025.111517_b0460","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00701-022-05154-5","article-title":"Cerebrospinal fluid and venous biomarkers of shunt-responsive idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis","volume":"164","author":"Thavarajasingam","year":"2022","journal-title":"Acta Neurochir (Wien)."}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825004904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825004904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:36:44Z","timestamp":1760139404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586825004904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":92,"alternative-id":["S0967586825004904"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111517","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers in normal pressure hydrocephalus: A mini review","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111517"}}